First-in-Class Isonipecotamide-Based Thrombin and Cholinesterase Dual Inhibitors with Potential for Alzheimer Disease

First-in-Class Isonipecotamide-Based Thrombin and Cholinesterase Dual Inhibitors with Potential for Alzheimer Disease

Recently, the direct thrombin (thr) inhibitor dabigatran has proven to be beneficial in animal models of Alzheimer’s disease (AD). Aiming at discovering novel multimodal agents addressing thr and AD-related targets, a selection of previously and newly synthesized potent thr and factor Xa (fXa) inhib...

Full description

Bibliographic Details
Main Authors: Rosa Purgatorio, Nicola Gambacorta, Modesto de Candia, Marco Catto, Mariagrazia Rullo, Leonardo Pisani, Orazio Nicolotti, Cosimo D. Altomare
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Molecules
Subjects:
acetylcholinesterase
butyrylcholinesterase
Alzheimer’s disease
antithrombotic agents
isonipecotamides
Online Access:https://www.mdpi.com/1420-3049/26/17/5208

Internet

https://www.mdpi.com/1420-3049/26/17/5208

Similar Items